A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer

BACKGROUND: The clinical behavior of prostate cancer (PCa) is variable, and while the majority of cases remain indolent, 10% of patients progress to deadly forms of the disease. Current clinical predictors used at the time of diagnosis have limitations to accurately establish progression risk. Here...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Georgescu, Constantin, Corbin, Joshua M., Thibivilliers, Sandra, Webb, Zachary D., Zhao, Yan D., Koster, Jan, Fung, Kar-Ming, Asch, Adam S., Wren, Jonathan D., Ruiz-Echevarría, Maria J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503380/
https://ncbi.nlm.nih.gov/pubmed/31060542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5592-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados